Ares Commercial Real Estate Corp current report, 17 June 2021

Business Context and Reporting Period

Ares Commercial Real Estate Corporation (ACRE), a Maryland corporation, filed this Form 8-K on June 17, 2021, to report the entry into a material definitive agreement. The company is an external manager-led real estate investment trust focused on commercial real estate.

Key Financial Metrics

This filing reports on a specific capital raising event rather than periodic operating results. Key financial data points include:

  • Shares Sold: 6,500,000 shares of common stock.
  • Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 975,000 shares.
  • Net Proceeds: Approximately $101.5 million (after deducting estimated transaction expenses).
  • Offering Close Date: June 22, 2021.

The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this is a transactional report, not a financial statement.

Material Changes

The primary material change is the increase in equity capital and share count resulting from the public offering. The company entered into an underwriting agreement with Morgan Stanley & Co. LLC, Wells Fargo Securities, LLC, and BofA Securities, Inc. as representatives. Additionally, the company agreed to a 30-day lock-up period, restricting the sale or transfer of common stock or convertible securities without underwriter consent following the June 22, 2021 closing.

Guidance, Outlook, and Risks

The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard terms of the underwriting agreement. The transaction was executed pursuant to an effective shelf registration statement on Form S-3 filed in July 2019. Legal opinions regarding the legality of the shares and tax matters were provided by Venable LLP and Kirkland & Ellis LLP, respectively.

Investor Verification Checklist

  • Verify the final number of shares issued if the 975,000 share over-allotment option is exercised.
  • Confirm the exact use of the $101.5 million in net proceeds in subsequent filings or press releases.
  • Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific indemnification rights and termination provisions.
  • Monitor the expiration of the 30-day lock-up period ending July 22, 2021, for potential secondary market impact.